The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_001114753.3(ENG):c.1701del (p.Val568fs)

CA913190140

618625 (ClinVar)

Gene: ENG (HGNC:2022)
Condition: telangiectasia, hereditary hemorrhagic, type 1 (MONDO:0008535)
Inheritance Mode: Autosomal dominant inheritance
UUID: 1faf3eb2-c488-4f8a-873e-9357828dcf78
Approved on: 2024-03-15
Published on: 2024-03-15

HGVS expressions

NM_001114753.3:c.1701del
NM_001114753.3(ENG):c.1701del (p.Val568fs)
NC_000009.12:g.127817189del
CM000671.2:g.127817189del
NC_000009.11:g.130579468del
CM000671.1:g.130579468del
NC_000009.10:g.129619289del
NG_009551.1:g.42580del
ENST00000480266.6:c.1155del
ENST00000373203.9:c.1701del
ENST00000344849.4:c.1701del
ENST00000373203.8:c.1701del
ENST00000480266.5:c.1155del
NM_000118.3:c.1701del
NM_001114753.2:c.1701del
NM_001278138.1:c.1155del
NR_136302.1:n.1124del
NM_001278138.2:c.1155del
More

Pathogenic

Met criteria codes 3
PM2_Supporting PS4_Supporting PVS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Hereditary Hemorrhagic Telangiectasia Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for ENG Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Hereditary Hemorrhagic Telangiectasia VCEP
The NM_001114753.3: c.1701del (p.Val568Serfs*5) variant in ENG is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 13 (out of 15) leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant has been reported in a proband with a phenotype consistent of HHT (PS4_Supporting; Internal lab contributors). In summary, this variant meets the criteria to be classified as pathogenic for autosomal dominant hereditary hemorrhagic telangiectasia based on the ACMG/AMP criteria applied, as specified by the ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel: PVS1, PM2_Supporting, PS4_Supporting (specification version 1.0.0; 1/4/2024).
Met criteria codes
PM2_Supporting
This variant is absent from gnomAD v2.1.1 (PM2_Supporting).
PS4_Supporting
This variant has been reported in a proband with a phenotype consistent of HHT (PS4_Supporting; Internal lab contributors).
PVS1
The NM_001114753.3: c.1701del (p.Val568Serfs*5) variant in ENG is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 13 (out of 15) leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.